Aligners – The Big Market

Align Technology is a medical device provider focused on malocclusion or teeth misalignment condition. Currently, around 60%–75% of the total world population is affected by this condition.

While ten million people in developed markets seek treatment from orthodontists every year, half of them suffer from mild to moderate malocclusion, which is the target market for Align Technology’s Invisalign system. Around 100 million people in the world prefer to straighten their teeth at home using clear aligner technology. This doctor-directed home market is also a major growth opportunity for Align Technology.

In 2016, the Clear Aligner segment reported revenues of close to $958.3 million, which made up 89% of the company’s total revenues. The Clear Aligner segment’s revenues are further categorized into a comprehensive product and non-comprehensive product revenues.

Comprehensive products involve Invisalign Full, Invisalign Teen, and Invisalign Assist product lines. While Invisalign Full consists of the set of aligners required by dentists, Invisalign Teen includes additional features suitable for teenage patients.

Notably, the Core S&P Mid-Cap ETF (IJH) has about 0.67% of its total portfolio holdings in Align Technology.

Source

Dental Implant Program

Dental Implant Program

IMG_20170616_011821 (1)

DentistryUnited Academy will be launching its maiden Implants program in Bangalore this July.

The program will be in 3 contact sessions of 3 days each for Basic Implantology.

The program will be unique and first of its kind where every participant will have an opportunity to work with the mentor during the 6 months period ( in private practice with the mentor for atleast 10 complete cases). This would give them immense exposure to clinical cases during these 6 months.

The detailed program will be out soon.

Please like or comment on this post to stay updated.

 

Pregnancy may be blocked by a Periodontal Pathogen Porphyromonas Gingivalis

Researchers at the University of Helsinki found  delay conception in young women could be associated with P Gingivalis.

The study, published June 12 in the Journal of Oral Microbiology, included 256 healthy, non-pregnant women ranging in age from 19 to 42 from Southern Finland who had discontinued contraception in order to become pregnant.

Participants were followed for a period of 12 months to determine whether they got pregnant during that time period.

The researchers found significantly higher levels of porphyromonas gingivalis, a bacterium associated with periodontal diseases, in the saliva of women who did not become pregnant during the study period compared to those who did become pregnant.

The women with P. gingivalis in their saliva had three times more difficulty getting pregnant compared to women without the bacterium.

Source

Easy Efficient Molar Endodontics – CDE

Easy Efficient Molar Endodontics – CDE

DentistryUnited Academy is happy to announce 2 days CDE program in Endodontics :

endo

 

Topics :

Diagnosis and Case Selection

Tips on Access Cavity Preparation

Shaping and Cleaning – Hand vs Rotary

Endodontic Irrigation Protocols

Apex Locators

Intracanal Medicaments

Various Rotary Endodontics systems

Obturation Techniques

Problem Solving in Endodontics

 

Faculty : Dr. Shiraz Pasha MDS

 Dates : 14/15 August 2017

Time : 10:30am – 5:00pm

Location : Bangalore

Fee : 18900/-

Fee includes Work-time Lunch/Snacks

For Details call : +91-98451 06626

Register by Transferring Rs. 5000/- online 

A/c :DentistryUnited.com – 0851131001573

IFSC : ORBC0100851

 

 

Align Technology – A business built on patents

Align Technology was founded in 1997 by two Stanford MBA students, Zia Chishti and Kelsey Wirth, who had no background in orthodontics (Chishti had undergraduate degrees in economics and computer science, Wirth in literature and American History). But the pair believed that a clear version of braces would be a huge hit, upending an industry that had been using roughly the same metal brackets-and-wires to straighten teeth for decades. Believers helped them raise $130 million in a 2001 public offering, but much of that money was blown on sales and marketing efforts, including a massive national direct to consumer ad campaign. They spent $52 million that same year but only sold $45 million worth of the aligners.

After years of tepid growth, Align’s Silicon Valley tech is winning over more customers in the slow-changing orthodontics business, boosting company sales 28% year-over-year. It has an estimated 80% of the North America “clear aligner” orthodontics market, and is offered by more than 50,000 orthodontists and dentists. Invisalign hit its 4 millionth patient in September. In 2016, sales hit $1 billion for the first time. The stock is up 62% in the last 12 months, well outpacing the S&P 500, which is up 13% in the same time. Its success is due to its near monopoly on clear braces, but also its patented processes that digitally map and build out a patient’s treatment.

Now the company is reaching a crossroads and some wonder if it can continue to deliver such sparkling returns. On the one hand, there are still plenty of teeth for it to straighten. Last year Invisalign products were used in roughly 8% of the 3 million new orthodontic patients in North America. On the other hand, one of its biggest advantages – its arsenal of more than 400 U.S. and 300 foreign-issued patents covering everything from the type of plastic that’s worn in patients’ mouths to the software orthodontists use to plan out teeth movements millimeter-by-millimeter, months in advance – is facing its term limits.